Header Logo

Connection

Ross Abrams to Chemotherapy, Adjuvant

Back to Details
This is a "connection" page, showing publications Ross Abrams has written about Chemotherapy, Adjuvant.
Ross Abrams
Connection Strength
2.242
Chemotherapy, Adjuvant
  1. Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial. Am J Clin Oncol. 2020 03; 43(3):173-179.
    View in: PubMed
    Score: 0.689
  2. Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985? Int J Radiat Oncol Biol Phys. 2003; 56(4 Suppl):3-9.
    View in: PubMed
    Score: 0.210
  3. Evolving concepts regarding the use of radiotherapy in the adjuvant management of periampullary pancreatic adenocarcinoma. Cancer J. 2012 Nov-Dec; 18(6):624-32.
    View in: PubMed
    Score: 0.104
  4. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma: is it helpful? Expert Rev Gastroenterol Hepatol. 2012 Apr; 6(2):149-61.
    View in: PubMed
    Score: 0.100
  5. Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):809-16.
    View in: PubMed
    Score: 0.092
  6. Review and commentary on the role of radiation therapy in the adjuvant management of pancreatic cancer. Am J Clin Oncol. 2010 Feb; 33(1):101-6.
    View in: PubMed
    Score: 0.086
  7. Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol. 2009 Jul; 16(7):1751-6.
    View in: PubMed
    Score: 0.081
  8. Management of a patient with borderline resectable pancreatic cancer. Case report and review. Oncology (Williston Park). 2008 Nov 30; 22(13):1524-9.
    View in: PubMed
    Score: 0.079
  9. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008 Jul 20; 26(21):3503-10.
    View in: PubMed
    Score: 0.077
  10. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007 Mar; 142(3):285-8.
    View in: PubMed
    Score: 0.070
  11. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys. 2007 May 01; 68(1):178-82.
    View in: PubMed
    Score: 0.070
  12. Comment on "adjuvant therapy in pancreatic cancer: a critical appraisal". Drugs. 2007; 67(17):2481-5; discussion 2491-3.
    View in: PubMed
    Score: 0.069
  13. Adjuvant therapy for pancreatic cancer: current status, future directions. Semin Oncol. 2006 Dec; 33(6 Suppl 11):S10-3.
    View in: PubMed
    Score: 0.069
  14. Radiotherapy in the adjuvant management of pancreatic adenocarcinoma. Semin Oncol. 2005 Dec; 32(6 Suppl 9):S30-2.
    View in: PubMed
    Score: 0.064
  15. Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings. Semin Radiat Oncol. 2005 Oct; 15(4):235-44.
    View in: PubMed
    Score: 0.063
  16. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Surg Oncol Clin N Am. 2004 Oct; 13(4):621-38, ix.
    View in: PubMed
    Score: 0.059
  17. Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet. 2001 Nov 10; 358(9293):1565-6.
    View in: PubMed
    Score: 0.048
  18. Adjuvant therapy for pancreatic adenocarcinoma. J Gastrointest Surg. 2001 Jan-Feb; 5(1):6-7.
    View in: PubMed
    Score: 0.046
  19. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys. 1999 Jul 15; 44(5):1039-46.
    View in: PubMed
    Score: 0.041
  20. Role of radiation therapy in the management of the patient with pancreatic cancer. Oncology (Williston Park). 1996 Sep; 10(9 Suppl):13-7.
    View in: PubMed
    Score: 0.034
  21. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
    View in: PubMed
    Score: 0.022
  22. Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b-based chemoradiation: ACOSOG Trial Z05031. Ann Oncol. 2011 Feb; 22(2):348-54.
    View in: PubMed
    Score: 0.022
  23. Postresection CA 19-9 predicts overall survival in patients with pancreatic cancer treated with adjuvant chemoradiation: a prospective validation by RTOG 9704. J Clin Oncol. 2008 Dec 20; 26(36):5918-22.
    View in: PubMed
    Score: 0.020
  24. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):1089-96.
    View in: PubMed
    Score: 0.011
  25. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg. 1997 May; 225(5):621-33; discussion 633-6.
    View in: PubMed
    Score: 0.009
  26. p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J Natl Cancer Inst. 1997 Jan 15; 89(2):158-65.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.